008730.KS KSC
Youlchon Chemical Co.,Ltd.
1W: +0.4%
1M: -8.4%
3M: -2.5%
YTD: -46.6%
1Y: -57.8%
3Y: -53.7%
5Y: -29.4%
₩14,930.00 ($11.11)
+120.00 (+0.81%)
Weekly Expected Move ±4.9%
₩13478
₩14204
₩14930
₩15656
₩16382
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$687.6B
+4.9% ▲
5Y CAGR: +2.3%
Total Liabilities
$395.3B
+8.5% ▲
5Y CAGR: +8.3%
Shareholders Equity
$292.2B
+0.4% ▲
5Y CAGR: -3.4%
Cash & Investments
$28.3B
+17.7% ▲
5Y CAGR: -3.1%
Total Debt
$287.2B
+6.9% ▲
5Y CAGR: +13.7%
Net Debt
$263.4B
+4.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $29.3B | $37.6B | $47.0B | $15.9B | $23.8B |
| Short-Term Investments | $37.9B | $55M | $121M | $8.2B | $4.5B |
| Cash & ST Investments | $67.2B | $37.7B | $47.2B | $24.0B | $28.3B |
| Net Receivables | $129.4B | $114.3B | $121.3B | $113.6B | $125.8B |
| Inventory | $70.3B | $82.5B | $73.3B | $74.6B | $89.9B |
| Other Current Assets | $1.1B | $1.7B | $17.3B | $988M | $1.2B |
| Total Current Assets | $269.1B | $237.3B | $260.4B | $216.0B | $246.6B |
| Property, Plant & Equip. | $379.3B | $384.4B | $396.9B | $413.6B | $419.2B |
| Goodwill & Intangibles | $17.4B | $15.5B | $13.6B | $10.1B | $9.0B |
| Long-Term Investments | -$37.1B | $882M | $2.4B | -$5.9B | $2.5B |
| Other Non-Current Assets | $0 | $16.0B | $5.7B | $20.4B | $8.6B |
| Total Non-Current Assets | $397.6B | $415.8B | $418.6B | $439.5B | $440.9B |
| Total Assets | $666.7B | $653.1B | $679.0B | $655.5B | $687.6B |
| — Liabilities — | |||||
| Accounts Payable | $60.7B | $58.8B | $51.7B | $47.1B | $62.9B |
| Short-Term Debt | $70.0B | $43.6B | $162.6B | $130.3B | $155.5B |
| Deferred Revenue | $36.1B | $3.4B | $0 | $0 | $0 |
| Other Current Liabilities | -$4.7B | $26.1B | $20.2B | $13.9B | $28.2B |
| Total Current Liabilities | $169.6B | $139.5B | $274.0B | $213.5B | $248.0B |
| Long-Term Debt | $130.8B | $162.1B | $84.2B | $137.4B | $131.2B |
| Other Non-Current Liab. | $8.5B | $6.4B | $7.1B | $10.9B | $15.6B |
| Total Non-Current Liabilities | $151.0B | $179.9B | $98.6B | $151.1B | $147.3B |
| Total Liabilities | $320.7B | $319.3B | $372.7B | $364.5B | $395.3B |
| — Equity — | |||||
| Common Stock | $14.8B | $14.8B | $14.8B | $14.8B | $14.8B |
| Retained Earnings | $321.6B | $309.2B | $281.6B | -$4.3B | $12.2B |
| Accumulated OCI | $310M | $452M | $467M | $271.1B | $255.8B |
| Total Stockholders Equity | $346.1B | $333.8B | $306.3B | $290.9B | $292.2B |
| Total Liabilities & Equity | $666.7B | $653.1B | $679.0B | $655.5B | $687.6B |
| — Key Metrics — | |||||
| Total Debt | $201.5B | $206.9B | $247.9B | $268.6B | $287.2B |
| Net Debt | $172.2B | $169.3B | $200.8B | $252.7B | $263.4B |
| Total Investments | $831M | $937M | $2.5B | $2.3B | $7.0B |